Disney/Maneesh Makes Play For Baby Care In India, Where J&J Is Big Daddy
This article was originally published in The Rose Sheet
Disney Consumer Products - part of the $35 billion Walt Disney Group - has teamed up with India's Maneesh Pharma for a share of the rapidly growing $250 million baby-care market
You may also be interested in...
Johnson & Johnson's new Clean & Clear Soft skin-care line caters to an underserved demographic by offering a "healthy daily regimen" for young women with normal, non-acne-troubled complexions, according to the company
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.
In a bold move, little known Indian drug firm Lee Pharma has applied for a compulsory license for saxagliptin in India, contending that AstraZeneca sells the diabetes drug at an exorbitant local price and that it is not being made sufficiently available. Lee also says that the originator has not responded to calls to collaborate.